RNA and Protein Granules: It's all starting to come together

  1. Lindsay A Becker  Is a corresponding author
  2. Aaron D Gitler  Is a corresponding author
  1. Stanford University School of Medicine, United States

The cell is an extremely busy and crowded place. To cope with the huge variety of biological processes that occur at the same time and in very close quarters, cells divide their interiors into compartments. Some of these compartments – for example, the nucleus – are surrounded by a membrane. Others, such as the nucleolus, are not membrane-bound but still play critical roles that are essential for life.

Ribonucleoprotein (RNP) granules are non-membrane bound compartments that form from RNA molecules and RNA-binding proteins. Different classes of RNPs carry out diverse roles: for example, some can regulate gene expression while another (the nucleolus) produces ribosomes.

RNP granules self-assemble from soluble proteins and RNAs to form structures that constantly grow, shrink, and fuse. Recent studies suggest that some RNP granules behave like liquids (Brangwynne et al., 2009), and several researchers have hypothesized that RNP granules form by ‘demixing’ (kind of like how tiny droplets of vinegar separate from the olive oil and fuse to form larger droplets in a vinaigrette salad dressing). These and other findings have revolutionized how scientists think about the organization of compartments within the cell and about the biochemistry of protein accumulations (Li et al., 2012).

Stress granules and processing bodies (also called P bodies) are two kinds of RNP granules. Cells form stress granules in response to stresses such as excessive heat. Stressed cells halt the production of most proteins, and the molecular machinery needed to build these proteins (including the mRNA transcripts) coalesces into short-lived stress granules in the cell's cytoplasm (Kedersha and Anderson, 2002). When the stress is resolved, these stress granules dissolve, and protein production is resumed. But if the stress persists, the mRNA transcripts within the stress granules can be transferred to P bodies and broken down (Parker and Sheth, 2007).

In order for the chemical reactions that degrade RNA to occur within P bodies, the compartments must provide a highly flexible environment (where molecules can freely move around). Stress granules, on the other hand, act more like storage depots. This means stress granules are unlikely to need to be as flexible as P bodies. But stress granules must still be able to readily dissolve once the stress is resolved so that their constituent parts can be reactivated.

Now, in eLife, Simon Alberti from the Max Planck Institute of Molecular Cell Biology and Genetics and colleagues – including Sonja Kroschwald as first author – present a comprehensive analysis of the material states of stress granules and P bodies and uncover some unexpected differences (Kroschwald et al., 2015).

Kroschwald et al. used an alcohol called hexanediol to distinguish between RNP granules with liquid-like and solid-like states in living cells. Hexanediol interferes with weak hydrophobic (‘water-hating’) interactions between molecules. Since liquid-like states involve weaker interactions than solid-like states, it was reasoned that liquid-like states would be disrupted by hexanediol but solid-state ones would not. Indeed, when yeast cells containing fluorescently tagged P bodies and stress granules were treated with hexanediol, the P bodies rapidly dissolved. Furthermore, this was reversible; the P bodies rapidly returned after the hexanediol was washed out.

Kroschwald et al. then performed time-lapse microscopy and saw that the smooth, spherical P bodies often fused with one another and then relaxed back into a spherical shape. Other techniques further confirmed that molecules frequently entered and left P bodies (as would be expected in a weak, liquid-like state). These chemical and cell biological data suggest that the protein building blocks of P bodies interact weakly and move a lot, just like the molecules in a liquid.

The yeast stress granules were quite different and instead behaved like unstructured, solid aggregates. Unlike the P bodies, the yeast stress granules did not dissolve in hexanediol and had a rough surface. Furthermore, the misfolded protein aggregates that form when yeast cells are heat shocked overlap with the locations of stress granules, but not P bodies.

Kroschwald et al. hypothesized that stress granules could be a kind of useful aggregate and that misfolded proteins might help stress granules to form (Cherkasov et al., 2013). To test this hypothesis, they engineered yeast cells to produce protein fragments that can assemble into a large spherical particle within living cells. They then genetically fused various misfolded proteins to these fragments, resulting in particles that had misfolded proteins on their surface. After a heat shock, stress granule proteins were rapidly recruited to the particles. However, stress granules did not form on particles that did not have misfolded proteins on their surface. This finding suggests that misfolded protein aggregates can act like a scaffold, allowing stress granule proteins to bind and recruit other constituent parts to coalesce into a mature stress granule.

Unexpectedly, Kroschwald et al. observed that stress granules in mammalian cells appeared more liquid-like than the solid-like yeast stress granules (Figure 1). They propose that this is because yeast cells have robust aggregate-dissolving machinery that can readily dissolve stress granules from their solid state, whereas mammalian cells do not.

Protein and RNA accumulations can take on multiple forms within a cell.

Kroschwald et al. report that, under healthy physiological conditions, P bodies in yeast and mammals and stress granules in mammals form liquid-like spheres (with weak bonds). Yeast stress granules form amorphous, unstructured solids, which are similar to aggregates of misfolded proteins. In several neurodegenerative diseases, insoluble deposits of proteins form structured assemblies with strong bonds, which are difficult to break down within cells. So-called ‘amyloid deposits’ are an example of this type of protein accumulation. These different states of matter are likely within a continuum, and the constituent components may undergo phase transitions to switch between different states under certain conditions. The color of the dashed lines indicates whether the states of matter on the continuum are considered healthy (“physiological”; blue) or potentially diseased (“pathological?”; purple) in mammals (top) and yeast (bottom). It is important to note that amyloid states in yeast (and potentially in mammals) can also be used for normal physiological processes.

These new results provide insight into a fundamental problem of cell biology, and may also be highly relevant to the development of several devastating human diseases. Neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), are associated with aggregates that contain some of the RNA-binding proteins that are also found in stress granules. Perhaps, in these neurodegenerative diseases, the nerve cells are killed when healthy RNP granules (with weak interactions) switch to a disease-causing insoluble state (with stronger interactions) (Li et al., 2013; Ramaswami et al., 2013). Indeed, Kroschwald et al. provide evidence that, in certain contexts, some proteins from P bodies and stress granules can form insoluble, immobile aggregates that are similar to those seen in these diseases.

Many questions lie ahead. How do P bodies and stress granules recruit their respective, distinct proteins given the weak and largely non-specific interactions that hold these components together? In mammalian cells, what stops liquid-like stress granules and P bodies from fusing? What controls whether different RNP granules take on liquid-like or disordered solid-like states? These and other questions are still unresolved and are an area of intense interest (Han et al., 2012; Kato et al., 2012). Characterizing the biochemical structures of protein accumulations, such as RNP granules, is not only relevant to our fundamental understanding of how cells work, it may also help unravel the causes of several neurodegenerative diseases.

References

Article and author information

Author details

  1. Lindsay A Becker

    Department of Genetics, Stanford University School of Medicine, Stanford, United States
    For correspondence
    labecker@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3034-6742
  2. Aaron D Gitler

    Department of Genetics, Stanford University School of Medicine, Stanford, United States
    For correspondence
    agitler@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: August 5, 2015 (version 1)

Copyright

© 2015, Becker and Gitler

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,619
    Page views
  • 480
    Downloads
  • 5
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lindsay A Becker
  2. Aaron D Gitler
(2015)
RNA and Protein Granules: It's all starting to come together
eLife 4:e09853.
https://doi.org/10.7554/eLife.09853

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Ivan Corbeski, Pablo Andrés Vargas-Rosales ... Amedeo Caflisch
    Research Article

    The complex of methyltransferase-like proteins 3 and 14 (METTL3-14) is the major enzyme that deposits N6-methyladenosine (m6A) modifications on messenger RNA (mRNA) in humans. METTL3-14 plays key roles in various biological processes through its methyltransferase (MTase) activity. However, little is known about its substrate recognition and methyl transfer mechanism from its cofactor and methyl donor S-adenosylmethionine (SAM). Here, we study the MTase mechanism of METTL3-14 by a combined experimental and multiscale simulation approach using bisubstrate analogues (BAs), conjugates of a SAM-like moiety connected to the N6-atom of adenosine. Molecular dynamics simulations based on crystal structures of METTL3-14 with BAs suggest that the Y406 side chain of METTL3 is involved in the recruitment of adenosine and release of m6A. A crystal structure with a BA representing the transition state of methyl transfer shows a direct involvement of the METTL3 side chains E481 and K513 in adenosine binding which is supported by mutational analysis. Quantum mechanics/molecular mechanics (QM/MM) free energy calculations indicate that methyl transfer occurs without prior deprotonation of adenosine-N6. Furthermore, the QM/MM calculations provide further support for the role of electrostatic contributions of E481 and K513 to catalysis. The multidisciplinary approach used here sheds light on the (co)substrate binding mechanism, catalytic step, and (co)product release, and suggests that the latter step is rate-limiting for METTL3. The atomistic information on the substrate binding and methyl transfer reaction of METTL3 can be useful for understanding the mechanisms of other RNA MTases and for the design of transition state analogues as their inhibitors.

    1. Biochemistry and Chemical Biology
    2. Developmental Biology
    Zhi Li, Yuedi Wang ... Zeyang Zhou
    Research Article

    Imidacloprid is a global health threat that severely poisons the economically and ecologically important honeybee pollinator, Apis mellifera. However, its effects on developing bee larvae remain largely unexplored. Our pilot study showed that imidacloprid causes developmental delay in bee larvae, but the underlying toxicological mechanisms remain incompletely understood. In this study, we exposed bee larvae to imidacloprid at environmentally relevant concentrations of 0.7, 1.2, 3.1, and 377 ppb. There was a marked dose-dependent delay in larval development, characterized by reductions in body mass, width, and growth index. However, imidacloprid did not affect on larval survival and food consumption. The primary toxicological effects induced by elevated concentrations of imidacloprid (377 ppb) included inhibition of neural transmission gene expression, induction of oxidative stress, gut structural damage, and apoptosis, inhibition of developmental regulatory hormones and genes, suppression of gene expression levels involved in proteolysis, amino acid transport, protein synthesis, carbohydrate catabolism, oxidative phosphorylation, and glycolysis energy production. In addition, we found that the larvae may use antioxidant defenses and P450 detoxification mechanisms to mitigate the effects of imidacloprid. Ultimately, this study provides the first evidence that environmentally exposed imidacloprid can affect the growth and development of bee larvae by disrupting molting regulation and limiting the metabolism and utilization of dietary nutrients and energy. These findings have broader implications for studies assessing pesticide hazards in other juvenile animals.